Pyrophosphorolysis activated polymerization (PAP)

• US 7,033,763 B2
• Filed: 05/09/2003
• Issued: 04/25/2006
• Est. Priority Date: 02/23/2000
• Status: Expired due to Term

• Current Assignee: City of Hope
• Original Assignee: City of Hope
• Inventors: Sommer, Steve S., Liu, Qiang, Riggs, Arthur D.
• Primary Examiner(s): Horlick, Kenneth R.
• Application Number:
  US10/434,369
• Publication Number:
  US 20040009515A1
• Time in Patent Office: 1,082 Days
• Field of Search: 435/6, 435/91.1, 435/91.2
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6858 Allele-specific amplification
• CPC Class Codes: C12Q 2521/319 Exonuclease
• CPC Class Codes: C12Q 2525/186 incorporating a non-extendable or blocking moiety
• CPC Class Codes: C12Q 2535/125 Allele specific primer extension
• CPC Class Codes: C12Q 2535/131 Allele specific probes
• CPC Class Codes: C12Q 2565/301 Pyrophosphate (PPi)

Abstract

A novel method of pyrophosphorolysis activated polymerization (PAP) has been developed. In PAP, pyrophosphorolysis and polymerization by DNA polymerase are coupled serially for each amplification by using an activatable oligonucleotide P* that has a non-extendible 3′-deoxynucleotide at its 3′ terminus. PAP can be applied for exponential amplification or for linear amplification. PAP can be applied to amplification of a rare allele in admixture with one or more wild-type alleles by using an activatable oligonucleotide P* that is an exact match at its 3′ end for the rare allele but has a mismatch at or rear its 3′ terminus for the wild-type allele. PAP is inhibited by a mismatch in the 3′ specific sequence as far as 16 nucleotides away from the 3′ terminus. PAP can greatly increase the specificity of detection of an extremely rare mutant allele in the presence of the wild-type allele. Specificity results from both pyrophosphorolysis and polymerization since significant nonspecific amplification requires the combination of mismatch pyrophosphorolysis and misincorporation by the DNA polymerase, an extremely rare event. Using genetically engineered DNA polymerases greatly improves the efficiency of PAP.

Claims

1. A method of detecting a nucleic acid which comprises:

(a) annealing to a nucleic acid a first oligonucleotide P*, wherein the first oligonucleotide P* has a non-extendable 3′

end, wherein the 3′

non-extendable terminus of first oligonucleotide P* is removable by pyrophosphorolysis;

(b) removing the 3′

non-extendable terminus of the first oligonucleotide P* by pyrophosphorolysis to produce an unblocked first oligonucleotide;

(c) extending the unblocked first oligonucleotide;

(d) detecting the presence of the nucleic acid by detecting the extended first oligonucleotide.

2. The method of claim 1, wherein pyrophosphorolysis is performed with a nucleic acid polymerase.

3. The method of claim 1, wherein extension is performed with a nucleic acid polymerase.

4. The method of claim 1, wherein a nucleotide or nucleotide analog present in the extension step contains a label and the presence of a label in the extended first oligonucleotide is detected.

5. The method of claim 1, wherein steps (a), (b) and (c) are repeated.

6. The method of claim 1, wherein the 3′

non-extendable terminus of first oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

7. The method of claim 6, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

8. The method of claim 1, wherein a second oligonucleotide is annealed to a complementary strand of the nucleic acid.

9. The method of claim 8, wherein the second oligonucleotide is an unblocked second oligonucleotide.

10. The method of claim 9, wherein the second oligonucleotide is extended in step (c).

11. method of claim 9, wherein the second oligonucleotide is a second oligonucleotide P* which has a non-extendable 3′

end, wherein the 3′

non-extendable terminus of the second oligonucleotide P* is removable by pyrophosphorolysis.

12. The method of claim 11, wherein the 3′

non-extendable terminus of the second oligonulceotide P* is removed by pyrophosphorolysis in step (b) to produce an unblocked second oligonucleotide and wherein the unblocked second olignonucleotide is extended in step (c).

13. The method of claim 11, wherein the 3′

non-extendable terminus of the second oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

14. The method of claim 13, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

15. The method of claim 11, wherein the 3′

non-extendable terminus of first oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis and wherein the 3′

non-extendable terminus of the second oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

16. The method of claim 15, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

17. A method of synthesizing a nucleic acid which comprises:

(a) annealing to a nucleic acid a first oligonucleotide P* which has a non-extendable 3′

end, wherein the 3′

non-extendable terminus of the first oligonucleotide P* is removable by pyrophosphorolysis;

(b) removing the 3′

non-extendable terminus of the first oligonucleotide P* annealed to the nucleic acid by pyrophosphorolysis; and

(c) extending the unblocked first oligonucleotide using a nucleic acid polymerase.

18. The method of claim 17, wherein steps (a) to (c) are repeated.

19. The method of claim 17, wherein pyrophosphorolysis and extension are performed with a nucleic acid polymerase.

20. The method of claim 17, wherein a second oligonucleotide is annealed to a nucleic acid strand which is the complement of said first strand.

21. The method of claim 20, wherein the second oligonucleotide is an unblocked second oligonucleotide.

22. The method of claim 21, wherein the second oligonucleotide is extended in step (c).

23. The method of claim 22, wherein steps (a) to (c) are repeated.

24. The method of claim 20, wherein the second oligonucleotide is a second oligonucleotide P* which has a non-extendable 3′

end, wherein the 3′

non-extendable terminus of the second oligonucleotide P* is removable by pyrophosphorolysis.

25. The method of claim 24, wherein steps (a) to (c) are repeated.

26. The method of claim 17, wherein the 3′

non-extendable terminus of first oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

27. The method of claim 26, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

28. The method of claim 24, wherein the 3′

non-extendable terminus of second oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

29. The method of claim 28, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

30. The method of claim 24, wherein the 3′

non-extendable terminus of first oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis and wherein the 3′

non-extendable terminus of the second oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

31. The method of claim 30, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

32. A method of detecting a nucleic acid which comprises:

(a) annealing to a nucleic acid two oligonucleotide P*s wherein each oligonucleotide P* has a non-extendable 3′

end, wherein the 3′

non-extendable terminus of each oligonucleotide P* is removable by pyrophosphorolysis, wherein one oligonucleotide P* overlaps with the other oligonucleotide P* by at least one nucleotide at their respective 3′

ends, and wherein one oligonucleotide P* anneals to a first nucleic acid strand and the other oligonucleotide P* anneals to a nucleic acid strand which is the complement of the first nucleic acid strand;

(b) removing the 3′

non-extendable terminus of the annealed first and second oligonucleotide P*s by pyrophosphorolysis to produce unblocked oligonucletides;

(c) extending the unblocked oligonucleotides; and

(d) detecting the extended oligonculeotides.

33. The method of claim 32, wherein pyrophosphorolysis is performed with a nucleic acid polymerase.

34. The method of claim 32, wherein extension is performed with a nucleic acid polymerase.

35. The method of claim 32, wherein pyrophosphorolysis and extension are performed with a nucleic acid polymerase.

36. The method of claim 32, wherein a nucleotide or nucleotide analog present in the extension step contains a label and the presence of a label in the extended oligonucleotide is detected.

37. The method of claim 32, wherein steps (a), (b) and (c) are repeated.

38. The method of claim 32, wherein the 3′

non-extendable terminus of each oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

39. The method of claim 38, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

40. A method of nucleic acid detection which comprises:

(a) synthesizing a template nucleic acid from the nucleic acid;

(b) annealing to the template nucleic acid a first oligonucleotide P* which has a non-extendable 3′

end, wherein the 3′

non-extendable terminus of the first oligonucleotide P* is removable by pyrophosphorolysis;

(c) removing the 3′

non-extendable terminus of the first oligonucleotide P* annealed to the template nucleic acid by pyrophosphorolysis; and

(d) extending the unblocked oligonucleotide.

41. The method of claim 40, wherein the template nucleic acid is synthesized by (i) annealing to one strand of the nucleic acid a first complementary oligonucleotide that is sequence specific and extending said first complementary oligonucleotide on the nucleic acid strand with a nucleic acid polymerase to produce an extended first oligonucleotide and (ii) adding a second oligonucleotide to a 3′

terminus of the extended first oligonucleotide to produce a template nucleic acid.

42. The method of claim 41, wherein the second oligonucleotide is added to the extended first complementary oligonucleotide by ligation.

43. The method of claim 41, wherein the second oligonucleotide is added to the extended first complementary oligonucleotide by terminal transferase extension.

44. The method of claim 41 which further comprises the step (a1) amplifying the template nucleic acid.

45. The method of claim 44, wherein the amplification is a polymerase chain reaction.

46. The method of claim 44, wherein the amplification is by a pyrophosphorolysis activated polymerization.

47. The method of claim 40, wherein the template nucleic acid is synthesized by a reaction which synthesizes copies of nucleic acid.

48. The method of claim 47, wherein the amplification reaction is a polymerization chain reaction.

49. The method of claim 47, wherein the amplification reaction is a pyrophosphorolysis activated polymerization reaction.

50. The method of claim 40, wherein pyrophosphorolysis is performed with a nucleic acid polymerase.

51. The method of claim 40, wherein extension is performed with a nucleic acid polymerase.

52. The method of claim 40, wherein pyrophosphorolysis and extension are performed with a nucleic acid polymerase.

53. The method of claim 52, wherein a nucleotide or nucleotide analog present in the extension step contains a label and the presence of the label in the extended oligonucleotide is detected.

54. The method of claim 40, wherein steps (a) to (d) are repeated.

55. The method of claim 40, wherein the 3′

non-extendable terminus of oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

56. The method of claim 55, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

57. The method of claim 40, wherein a second oligonucleotide is annealed to the template nucleic acid in step (b).

58. The method of claim 57, wherein the second oligonucleotide is an unblocked second oligonucleotide which is extended in step (d).

59. The method of claim 57, wherein the second oligonucleotide is a second oligonucleotide P* which has a non-extendable 3′

end, wherein the 3′

non-extendable terminus of the second oligonucleotide P* is removed by pyrophosphorolysis in step (c) to produce an unblocked second oligonucleotide and wherein the unblocked second olignonucleotide is extended in step (d).

60. The method of claim 59, wherein the 3′

non-extendable terminus of second oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

61. The method of claim 60, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

62. The method of claim 59, wherein the 3′

non-extendable terminus of second oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

63. The method of claim 62, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

64. The method of claim 59, wherein the 3′

non-extendable terminus of first oligonucleotide P* is a nucleotide or nucleotide analog which cannot be extended by a nucleic acid polymerase but which can be removed by pyrophosphorolysis.

65. The method of claim 64, wherein the nucleotide or nucleotide analog is selected from the group consisting of a 3′

deoxynucleotide, a 2′

,3′

-dideoxynucleotide, an acyclonucleotide, 3′

-deoxyadenosine (cordycepin), 3′

-azido-3′

-deoxythymidine (AZT), 2′

,3′

-dideoxyinosine (ddI), 2′

,3′

-dideoxy-3′

-thiacytidine (3TC) and 2′

,3′

-didehydro-2′

,3′

-dideoxythymidine (d4T).

66. The method of claim 40, wherein the nucleic acid is a nucleic acid that has been cleaved.

67. The method of claim 40, wherein the nucleic acid is a double stranded nucleic acid that has a lesion or a nick.

68. A pyrophosphorolysis activated polymerization method of synthesizing a desired nucleic acid strand on a nucleic acid template strand which comprises serially

(a) annealing to the template strand an activatable oligonucleotide P* that has a non-extendable 3′

-deoxynucleotide at its 3′

terminus and has a mismatch with respect to the corresponding nucleotide on the template strand,

(b) pyrophosphorolyzing the resulting duplex with pyrophosphate and an enzyme that has pyrophosphorolysis activity and activates the oligonucleotide P* by removal of the terminal 3′

-deoxynucleotide, and

(c) polymerizing by extending the activated oligonucleotide P* on the template strand in presence of four nucleoside triphosphates and a nucleic acid polymerase to synthesize the desired nucleic acid strand.

69. The pyrophosphorolysis activated polymerization method of claim 68 that includes amplification of the desired nucleic acid strand by

(d) separating the desired nucleic acid strand of step (c) from the template strand and

(e) repeating steps (a)–

(d) until a desired level of amplification of the desired nucleic acid strand is achieved.

70. The pyrophosphorolysis activated polymerization method of claim 69 carried out in the presence of a second oligonucleotide that in step (a) anneals to the separated desired nucleic acid strand product of step (d), and wherein step (c) includes polymerizing by extending the second oligonucleotide on the desired nucleic acid strand to synthesize a copy of the nucleic acid template strand, and step (d) includes separating the synthesized nucleic acid template strand from the desired nucleic acid strand, so that amplification is exponential.

71. The pyrophosphorolysis activated polymerization method of claim 70 wherein a mismatch between the activatable oligonucleotide P* and the template strand occurs with respect to the corresponding nucleotide on the template.

72. The pyrophosphorolysis activated polymerization method claim of 69 wherein steps (a) to (c) are conducted sequentially as two or more temperature stages on a thermocycler.